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ORIGINAL ARTICLE
Views of Dutch general practitioners about premenstrual symptoms:
A qualitative interview study
Marijke S. Labots-Vogelesang , Doreth A. M. Teunissen , Vivianne Kranenburg and
Antoine L. M. Lagro-Janssen
Gender and Women’s Health Unit, Department of Primary and Community Care, Radboud University Medical Centre, Nijmegen,
The Netherlands
KEY MESSAGES
 GPs consider PMS as a physiological hormonal condition, triggered by a personal sensitivity, not as
an illness
 GPs mainly use history taking to diagnose PMS, without a symptom diary as diagnostic tool
 GPs prefer a symptom-oriented approach with explanation, lifestyle advice, contraceptive hormones and if
necessary psychological support
ABSTRACT
Background: General practitioners (GPs) encounter women suffering from premenstrual symp-
toms. Often women with premenstrual problems experience little understanding from GPs.
Views of GPs will influence their approach to these women and their care. Insight into these
views is lacking but could help in designing educational programmes for GPs.
Objectives: To explore the views of Dutch GPs towards aetiology, diagnostic process, and pre-
ferred treatment of premenstrual symptoms.
Methods: In 2017, we conducted a qualitative, semi-structured, interview survey among 27 GPs,
varying in age, gender, and practice setting.
Results: Important themes emerged from the interviews: ‘no need for a symptom diary,’ ‘PMS
defined as illness’ exclusively in case of disruption of normal functioning, and ‘symptomatic
treatment’ as preferred approach. Most GPs considered PMS to be a physiological phenomenon,
with taking history as an adequate diagnostic tool. Almost all GPs regarded a normal cyclical
hormonal cycle as causal; many also mentioned the combination with personal sensitivity. Some
pointed to a dividing line between physiological condition and illness if women could not func-
tion normally in daily life. Lastly, the approach GPs preferred was focussing on relieving symp-
toms of individual patients. In addition to explaining the hormonal cycle and lifestyle advice, all
GPs advocated oral contraceptives, and if necessary psychological support. GPs expressed nega-
tive feelings about prescribing antidepressants.
Conclusion: GPs considered physiological changes and personal sensitivity as aetiological fac-
tors. We recommend more training to improve GPs knowledge and more insight into the bur-
den of women with PMS. A symptom diary is an essential diagnostic tool for GPs.
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Premenstrual syndrome (PMS) covers a broad spec-
trum of physiological and psychological symptoms
that may disrupt women’s daily lives. Characteristic of
PMS is the cyclic occurrence of symptoms in the luteal
phase of the menstrual cycle [1]. There is a strict dis-
tinction between PMS and Premenstrual Dysphoric
Disorder (PMDD), described in the DSM-5 as set out in
Box 1. Compulsory diagnostic criteria for PMDD are
that in most menstrual cycles during the past year,
five (or more) of the symptoms described in Box 1
occurred during the final week before the onset of
menses. These started to improve within a few days
after the onset of the menses, and the symptoms
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were minimal or absent in the week post menses,
regarding at least one of the emotional symptoms
lability, irritability, depressed mood, anxiety and as
physical symptoms painful breasts and bloating.
PMS, which is not an official DSM-5 diagnosis,
requires only one clinically significant cyclical symptom
across the cycle that can be physical or psychological.
The severity of the complaints distinguishes between
PMS and PMDD. There are several homonymous descrip-
tions of PMS without a numerical criterion for complaints
[2,3]. The most common symptoms of PMS are painful
breasts, bloating and emotional symptoms of which irrit-
ability is the most characteristic phenomenon [4].
Prospective and retrospective European studies
have shown that 4–8% of women of fertile age, with
hormonal cycles, have moderate to severe symptoms
[4,5]. The reported diversity in the prevalence of PMS
in the literature may depend on beliefs about the syn-
drome and in particular on the definitions used [2–8].
A lower threshold value for complaints at PMS than at
PMDD directly implies a higher prevalence than in
case of the strict criteria according to the DSM-5.
The aetiology of PMS is an issue of ongoing
research and debate, as we still do not fully under-
stand who has it and what causes it. Currently, there
is more clarity about the underlying pathophysiology
of an abnormal sensitivity and excessive response to
normal hormonal changes [9,10].
Hormonal changes disturb the neurotransmitter metab-
olism and thus affect the physiological stress response in
women with PMS. This may result in more susceptibility
to stress and more negative emotions [9,11–13]. Especially
in relationships, stress and ways of coping with PMS can
strongly influence womens distress. This altered stress
response pattern appears to be independent of the men-
strual cycle [11–14]. Personal sensitivity, genetic and evo-
lutionary factors can play a role in this [11,14,15].
Women suffering from PMS may experience a high
symptom burden and serious impairment in daily life
and will therefore seek help [5]. The psychic symptoms
strongly interfere with their self-perception and feminine
identity. GPs are the professionals most likely to be
called upon to deal with women with PMS. Women
often mention experiencing little acknowledgement and
understanding from their GP when they consult with
premenstrual symptoms and problems [personal com-
munication]. To our knowledge, there is no consensus
guideline for primary care about PMS and the perspec-
tives and attitudes of GPs towards PMS have been
scarcely investigated. The existing consensus developed
by the International Society for Premenstrual Disorders is
based on specialist research [16].
To improve the quality of care for women with
PMS, we aimed to investigate the views of GPs about
PMS, how GPs in daily practice diagnose complaints
fitting PMS and how they prefer to address the prob-
lem. We formulated the following questions: how do
Dutch GPs understand and explain the aetiology of
PMS, how do they make a diagnosis and what do GPs
think is the most appropriate treatment of PMS?
Methods
Study design
We performed a qualitative study based on individual
in-depth semi-structured interviews.
Box 1. Criteria for Premenstrual Dysphoric Disorder as
defined in the DSM-5
A. In most menstrual cycles during the past year, five (or
more) of the following symptoms occurred during the final
week before the onset of menses, started to improve within
a few days after the onset of the menses, and were min-
imal or absent in the week post menses, with at least one
of the symptoms being either (1), (2), (3) or (4):
1. Marked affective lability (e.g. mood swings, feeling sud-
denly sad or tearful or increased sensitivity to rejection);
2. Marked irritability or anger or increased interper-
sonal conflicts;
3. Marked depressed mood, feelings of hopelessness,
or self-deprecating thoughts;
4. Marked anxiety, tension, feelings of being ‘keyed
up’ or ‘on edge;’
5. Decreased interest in usual activities (e.g. work,
school, friends, hobbies);
6. Subjective sense of difficulty in concentrating;
7. Lethargy, easy fatiguability, or marked lack of energy;
8. Marked change in appetite, overeating, or specific
food cravings;
9. Hypersomnia or insomnia.
10. A subjective sense of being overwhelmed or out
of control.
11. Other physical symptoms, such as breast tenderness
or swelling, joint or muscle pain, a sensation of ‘bloating,’
weight gain.
B. The symptoms are associated with clinically significant distress
or inference with work, school, usual social activities or rela-
tionships with others (e.g. avoidance of social activities,
decreased productivity and efficiency at work or school).
C. The disturbance is not merely an exacerbation of the symp-
toms of another disorder, such as major depressive disorder,
panic disorder, dysthymic disorder, or a personality disorder
(although it may co-occur with any of these disorders);
D. Criteria A, B, and C must be confirmed by prospective daily
ratings during at least two symptomatic cycles. (The diag-
nosis may be provisionally prior to this confirmation);
E. The symptoms are not due to the direct physiological effects of
a substance (e.g. drug of abuse, a medication, or other treat-
ment) or a general medical condition (e.g. hyperthyroidism).
# American Psychiatric Association. 2013. ISBN 978-0-89042-
554-1
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For practical reasons, we preferred to conduct inter-
views above focus groups to reach GPs, willing to dis-
cuss PMS, from all over the country, with possible
diversity in gender, age, practice and place
of residence.
Study population
We recruited GPs through work-related networks using
a purposive sampling strategy aiming for sufficient
variation in age, gender, characteristics of practice
(solo, duo, healthcare centre, consultation days per
week), practice population and settings (city:
>200,000, suburban: 50,000–200,000, rural: <50,000
inhabitants and sparsely populated area) and location
in the Netherlands. We invited participants by tele-
phone or e-mail. GPs received an explanation about
the research project by e-mail. The GPs filled out a
questionnaire on the above mentioned background
characteristics.
Data collection
In early 2017 two experienced researchers from the
Department of Primary and Community Care and
Gender & Women’s Health (ML, VK) at Radboud
University Medical Centre conducted in-depth, semi-
structured interviews using an interview guide. The
interview guide was compiled based on the literature
and supervisors’ expert opinions (ML, TT, ALM) (Box 2).
We interviewed the participants by telephone for
practical reasons and based on findings indicating that
telephone interviews are as valuable as face-to-face
interviews [17]. The participants were asked to give
their written informed consent prior to the interviews.
Two interviews were used as a pilot; these are not
included in the study. Participants received no reward.
Analysis
Interviews were recorded on audio equipment with
the participants’ consent and were transcribed verba-
tim. Participants’ names were removed from the tran-
scripts and only the researchers had access to the
original interviews. Two researchers (ML, VK) inde-
pendently analysed the transcripts using Atlas.ti, ver-
sion 7.1.5 [18]. Coding was done following open, axial
and selective coding. Two independent researchers
read the transcripts and used open coding to concep-
tualise the data. The codes were compared and dis-
cussed after every five interviews to reach consensus.
When open coding was completed, axial coding was
started by reflecting on the codes and rewriting them
in categories. Lastly, these categories were conducted
in overarching themes [19]. The researchers discussed
all findings with the supervising committee (TT, ALM)
until they reached consensus. After 21 interviews no
more new codes were found, and thus saturation was
achieved. We provided figures to indicate whether the
results had been obtained from few (1–3), some (4–8),
many (9–18), or most (19–28) participants. COREQ cri-
teria were applied for reporting qualitative
research [20].
Results
We invited 30 GPs for an interview. In total, 27 con-
sented to participate, of whom were ten males and 17
females with a mean age of 58.8 years. After reaching
saturation, we still took another six interviews due to
logistical agreements. The sample was diverse regard-
ing years of practising and other background features.
An overview of the characteristics of the participants
is presented in Table 1.
For all GPs, history taking was based on the charac-
teristic premenstrual symptoms. The aetiology of PMS
was not a topic of debate among most participants.
They did not perform a further investigation into a
possible cause of the complaints. Their views on aeti-
ology are reflected in the quotations presented.
We subdivided the relevant views emerging from
our analysis of the data into the following themes: no
need for a symptom diary; disruption of normal func-
tioning as definition of illness; and lastly a symptom-
atic treatment approach.
No need for a symptom diary
All GPs diagnosed PMS based on history taking with
the cyclically related symptoms as the key point.
Box 2. Interview topic guide
Views about PMS
What is your opinion about the aetiology and the illness
concept of PMS?
How do you diagnose PMS complaints and symptoms?
Views about treatment of PMS
What is your first option in the approach to PMS?
Which treatment do you prefer for PMS? And why?
Which treatment dont you prefer? And why?
What is your view on psychological treatment and on
medication as hormones and antidepressants?
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‘Mostly, it is anamnestically quite clear, for the women
themselves.’ P17, female, 38yrs
The GPs did not perform a further investigation
into a possible cause of the complaints, as they con-
sidered diagnosing not helpful. They did so because
the definitive cause of PMS was not an issue in most
of the participants.
‘Well, we don’t know so. Point.’ P11, male, 65yrs
A few GPs did use a tool like a symptom diary or a
questionnaire to confirm the diagnosis.
Disruption of normal functioning as definition
of illness
Many GPs assumed that PMS is most likely related to
cyclical hormone changes only and is therefore purely
physiological.
‘I see it as a problem, as a situation belonging to the
normal physiological functioning of the body. There are
women with dysmenorrhea, is that a problem? Yes, for
women it may be a problem, but is it a medical problem?
No, not really, but it can still bother them. [… ] It’s
physiological, not an illness.’ P7, male, 58yrs
Many GPs added that contextual factors as well as
the patients suffering and coping strategies, contrib-
ute to being prone to premenstrual complaints.
‘But I also think it has to do with environmental factors,
psychological well-being, and balancing between
suffering and coping strategies of patients.’ P8,
female, 46yrs
A few GPs put the symptoms under the umbrella of
‘medically unexplained symptoms’ (MUS). They
seemed to regard PMS as a fashion trend that comes
and goes like a wave movement.
‘Anything that causes unwellness affects people who are
sensitive to MUS (… ).’ P15, male, 57yrs
GPs also described patients’ individual sensitivity
and mental well-being as contributing to PMS, as if
passing a certain level.
‘Well, [… ] people all have their own sensitivities and
you have to pass a sort of threshold for the symptoms
to appear. And I think those thresholds differ between
people.’ P32, male, 54yrs
Some GPs assumed the possibility of a genetic pre-
disposition to develop PMS. A few other GPs men-
tioned that PMS is not purely physiological but an
abnormal serotonin metabolism as potentially contri-
buting to changes in serotonin activity related to
mood state and developing PMS.
GPs considered PMS as an illness, only in case
severe symptoms forced women to seek help. The
dividing line, they found, was the point at which PMS
disrupted women’s daily life, when they suffered from
anger, felt anxious, guilty or gloomy, in such a debili-
tating way, that they could no longer func-
tion normally.
Table 1. Participants’ characteristics (n¼ 27).
Gender
Female 17
Mean age yrs. (SD) 44.4 (10.5)
Male 10
Mean age yrs. (SD) 58.5 (11.8)
Age (years)  40 8
41-55 8
> 55 11




Consultation days p/week Part-time  2 4
Part time (> 2-4) 16
Full time 5
Setting general practice Solo 9
Duo 8
Healthcare centre 10
Area of practice situation City 2
Suburban 15
Rural 10
Characteristics of practice population Elderly patients 6
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‘There are, of course also different graduations.[… ] And
when do you name it PMS?[… ] Only when you really
notice it in your daily life, that it gets in your way.’ P17,
female, 38yrs
For a single GP, it was clear that PMS could take
forms as in Premenstrual Dysphoric Disorder if the
PMS-symptoms were really intense and had a detri-
mental effect on the womans environment.
‘I met someone who rebuffed people during that one
week, which was not easy to retrieve within three
weeks. I saw relationships broken by PMS. I think it
requires treatment, so in that sense … an illness. [… ]I
think its pathology.’ P23, male, 73yrs
A symptomatic treatment approach
Almost all GPs first opted for a symptomatic treatment
approach focussing on the symptoms presented and
explaining the course of the hormonal cycle. In add-
ition, they advised the women to look for a lifestyle
fitting their personal context and for more time and
attention for themselves.
‘Well, [… ] it’s a burden, how much space do you allow
yourself, and how much do you want to claim, if you
don’t feel well around that period [… ]: ask for this
space!’ P11, male, 65yrs
Most GPs preferred a hormonal approach as a next
step. In shared decision making, they usually pre-
scribed oral contraceptives – cyclically or continuously
– or hormone-releasing IUD, possibly assuming that
the reduction of hormonal changes would also pre-
vent the occurrence of premenstrual symptoms.
‘It depends on the wish of the woman, somewhat, and
the course of the consultation [… ] If women want to
be treated [… ], then I think about treatment. But most
women reject it, run away from it.’ (Hormones) P8,
female, 46yrs
To support coping strategies and lifestyle, most GPs
thought positively about psychological support. They
provided this support preferably by themselves or
otherwise by their mental health nurse. A minority
referred to a psychologist.
‘When I think: this woman is overburdened, and I
suspect aspects of PMS, then I offer support from our
mental health nurse.’ P18, female, 48yrs
Some GPs did not favour a psychological approach
because they doubted its benefits. They considered
PMS as a hormonal dysfunctional condition that also
should be treated as such.
‘When you think of a physical cause, - that it’s in the
hormones – and you come up with cognitive
behavioural therapy [… ], it would be one of my last
choices. When medical treatment doesn’t work you
could add this option.’ P3, female, 36yrs
Opinions about prescribing antidepressants were
explicitly negative. Many GPs never prescribed them
because of the side-effects, insufficient experience or
because they were generally careful with prescribing
antidepressants.
‘I don’t prefer antidepressants. [… ]. Since PMS is
hormonal … and if you feel fine the other weeks of the
cycle, you take the antidepressants during those weeks
for nothing.’ P20, male, 65yrs
As final option many GPs were willingly prescribing
them at a later stage, only if really necessary.
‘Well usually, [… ]. I wont. [… ] If complaints keep
disrupting, or patients have a history of psychological
complaints, I discuss treatment with an antidepressant,
depending on their history.’ P25, female, 45yrs
Discussion
Main findings
This qualitative study sought to investigate the per-
spective of Dutch GPs towards aetiology, the diagnos-
tic process and subsequent management of PMS.
Although there is ongoing research and debate on
its aetiology in the PMS literature, this study does not
demonstrate that this is a matter of debate among
the 27 interviewed Dutch GPs. The vast majority of
the GPs considered PMS to be an intrinsic physio-
logical phenomenon caused by cyclical hormonal
changes. They rarely used a symptom diary to confirm
the diagnosis. Only some GPs considered PMS to be
an illness, in the case of irreversible impairments dis-
rupting the woman’s daily life. Others pointed out a
correlation between PMS, medically unexplained
symptoms, abnormalities in serotonin activity, or a
genetic predisposition, but these hypotheses did not
seem to affect their proposed PMS policy. Most partici-
pants stand for a symptomatic treatment approach,
explaining the cyclical nature of the menstrual cycle
and offering lifestyle advice fitting to the context of
the woman. Using a shared decision-making approach
hormonal therapy was advised, usually oral contracep-
tives or a hormone-releasing IUD. Psychological sup-
port was a third step of the policy, given by
themselves, or by referral to the mental health nurse,
if available in the GP practice, or a psychologist. GPs
preferred not to prescribe antidepressants.
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Comparison with the literature
Aetiology of PMS. About the aetiology, we found that
GPs merely assumed PMS to be a physiological phe-
nomenon. Why some women get symptoms and
others do not is unknown. This finding does not cor-
respond with the current views about PMS/PMDD.
Although PMS/PMDD’s aetiology is still not fully
understood, a currently widely accepted assumption is
that underlying pathophysiology is an abnormal sensi-
tivity to normal changes of ovarian hormones [10,11].
This hormone sensitivity has been associated with
genetic and biographic factors like history of
trauma [9,10,21,22].
Diagnosing PMS. Our finding that most GPs diag-
nosed PMS/PMDD based on history of the patient is in
line with studies indicating that about 90% of clini-
cians who treat PMDD rely on patients’ retrospective
self-report to make the diagnosis [22–24]. However,
studies comparing retrospective and prospective PMS/
PMDD symptoms have found a remarkable bias
towards false positive reports in retrospective self-
report measures of premenstrual changes in affect
[4,16,25]. Other studies have found that these meas-
ures are strongly influenced by clinicians’ beliefs and
opinions about PMS [22,23]. The diagnostic process of
PMS and PMDD requires a prospective method of
monitoring with validated instruments. The cyclicity of
symptoms should be determined with a prospectively
maintained symptom diary, for at least two consecu-
tive menstrual cycles [26]. In this way, a woman with
few pronounced complaints is more likely to receive
the correct diagnosis.
Impact of PMS on daily life. Our finding that GPs
consider PMS as an illness only in case of impairment
if PMS disrupts women’s daily life does not fit the
diagnosis of PMDD. To meet the DSM-5 diagnosis
PMDD, a premenstrual increase in five premenstrual
symptoms is necessarily combined with clinically sig-
nificant distress or interference with work, school,
usual activities or relationships with others. In diagnos-
ing PMS per DSM-5, having impairment is optional.
This allows the so-called silent sufferers with distress
but without impairment to receive a correct diagnosis
as well.
Symptomatic treatment approach. In daily practice,
GPs strive to clarify patients’ complaints in short con-
sultations and propose a suitable approach to their
problems in shared decision-making. This fits in with
patient-centred care which general practice currently
advocates. If desired, and to reduce hormonal
changes, the GP can in shared decision-making advise
on hormonal contraception. However, there is no con-
clusive evidence for a long-term effect on PMS com-
plaints [27–29].
GPs did not consider Cognitive Behavioural Therapy
(CBT) as a treatment option. There is growing evi-
dence that CBT can contribute to reducing symptoms
in women with PMS [30,31].
GPs’ opinions about prescribing antidepressants
were explicitly negative; SSRIs are not indicated as
first-choice therapy for women with PMS. SSRIs are
suitable for the severe forms of PMDD due to their
immediate effect, with low or even imtermittent dos-
age. Nevertheless, SSRIs currently are recommended
as gold standard treatment in clinical prac-
tice [29,32,33].
Strength and limitations. The interviewed GPs consti-
tuted a wide variety of gender, age, experience, and
practical circumstances. GPs from cultural minorities,
however, were lacking. In addition, voluntary participa-
tion may have caused selection bias when participants
with little interest in PMS are under-represented.
Notwithstanding that, we deem PMS views from our
participants a true reflection of the commonly applied
approach. As qualitative studies by nature are not
generalisable to a broader population, this also applies
to our study on women with premenstrual syndrome.
Implications for practice. We have to develop a reli-
able and valid diagnostic procedure in primary care
for PMS/PMDD. We highly recommend a training and
awareness project aimed at increasing knowledge
and adequately diagnosing PMS. GPs must acknow-
ledge that for the diagnosis of PMDD, in addition to
severe symptoms, the presence of impairment is not
required. GPs have to take women’s complaints ser-
iously, regardless of the level of impairment. We
advocate the use of a questionnaire and daily symp-
tom monitoring in diagnosing PMS. This will improve
the satisfaction of both GPs and women with PMS,
as well as the sense of being understood in women
with PMS. Highlighting the specific benefits of an
SSRI in women with severe premenstrual complaints
as PMDD is explicitly part of the training. To provide
more evidence for optimal management of PMS, we
advocate a study comparing cognitive behavioural
therapy with hormonal contraception for women
with premenstrual syndrome. The outcome might
function as a basis for education and a future guide-
line for primary care.
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In conclusion, most interviewed GPs considered
physiological hormonal changes and personal sensitiv-
ity important aetiological factors for PMS. Without
using a symptom diary for measuring the distress and
impairment in their daily lives, they opted for a symp-
tomatic approach to the complaints. They prefer hor-
monal contraception above SSRIs.
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